Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Engelhardt

Showing results (121-130 of 227) with videos related to

Pageof 23
Sort By:
Cancer Medicine|September 15, 2020
Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in GermanyKhalid Shoumariyeh, Francesca Biavasco, Gabriele Ihorst, et al.
Haematologica|October 15, 2020
Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myelomaSandra Maria Dold, Veronika Riebl, Dagmar Wider, et al.
Leukemia & Lymphoma|March 24, 2018
Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials<sup/>Laura Gengenbach, Heike Reinhardt, Gabriele Ihorst, et al.
The Oncologist|July 2, 2024
Physical activity and exercise motivation of multiple myeloma patients: a prospective cross-sectional studyJan Räder, Gabriele Ihorst, Mandy-Deborah Möller, et al.
Leukemia & Lymphoma|December 14, 2011
Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapyMartina Kleber, Josefina Udi, Barbara Metzke, et al.
Haematologica|July 11, 2015
Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 yearsMonika Engelhardt, Gabriele Ihorst, Ola Landgren, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|December 15, 2018
Kidney embolization induces prompt organ response in a 86-year-old patient with MGRS-related AL-amyloidosisSebastian Küchlin, Johannes Duffner, Sophia Scheubeck, et al.
Cancer|January 30, 2019
Avoiding chemotherapy prescribing errors: Analysis and innovative strategiesHeike Reinhardt, Petra Otte, Alison G Eggleton, et al.
Journal of Geriatric Oncology|November 23, 2020
Physical activity is associated with less comorbidity, better treatment tolerance and improved response in patients with multiple myeloma undergoing stem cell transplantationMandy-Deborah Möller, Gabriele Ihorst, Antonia Pahl, et al.
Haematologica|September 22, 2018
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of lifeChristine Greil, Monika Engelhardt, Gabriele Ihorst, et al.
Pageof 23

Showing results (121-130 of 227) with videos related to

Sort By:
Pageof 23
Cancer Medicine|September 15, 2020
Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in GermanyKhalid Shoumariyeh, Francesca Biavasco, Gabriele Ihorst, et al.
Haematologica|October 15, 2020
Validated single-tube multiparameter flow cytometry approach for the assessment of minimal residual disease in multiple myelomaSandra Maria Dold, Veronika Riebl, Dagmar Wider, et al.
Leukemia & Lymphoma|March 24, 2018
Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials<sup/>Laura Gengenbach, Heike Reinhardt, Gabriele Ihorst, et al.
The Oncologist|July 2, 2024
Physical activity and exercise motivation of multiple myeloma patients: a prospective cross-sectional studyJan Räder, Gabriele Ihorst, Mandy-Deborah Möller, et al.
Leukemia & Lymphoma|December 14, 2011
Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapyMartina Kleber, Josefina Udi, Barbara Metzke, et al.
Haematologica|July 11, 2015
Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 yearsMonika Engelhardt, Gabriele Ihorst, Ola Landgren, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|December 15, 2018
Kidney embolization induces prompt organ response in a 86-year-old patient with MGRS-related AL-amyloidosisSebastian Küchlin, Johannes Duffner, Sophia Scheubeck, et al.
Cancer|January 30, 2019
Avoiding chemotherapy prescribing errors: Analysis and innovative strategiesHeike Reinhardt, Petra Otte, Alison G Eggleton, et al.
Journal of Geriatric Oncology|November 23, 2020
Physical activity is associated with less comorbidity, better treatment tolerance and improved response in patients with multiple myeloma undergoing stem cell transplantationMandy-Deborah Möller, Gabriele Ihorst, Antonia Pahl, et al.
Haematologica|September 22, 2018
Allogeneic transplantation of multiple myeloma patients may allow long-term survival in carefully selected patients with acceptable toxicity and preserved quality of lifeChristine Greil, Monika Engelhardt, Gabriele Ihorst, et al.
Pageof 23